Fri, Aug 29, 2014, 11:20 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Rosetta Genomics, Ltd. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • vvvvvvrebel89130 vvvvvvrebel89130 May 20, 2012 6:32 AM Flag

    So they now have 1.8 MM shares OS and $3 million cash

    good analysis and conservative too

    2k reimbursement rate when the company mentioned in the article has a reimbursement rate of $3500

    that's the next bomb to drop; the pr said they would get the reimbursement rate soon from medicare

    only problem is how do they get to 20k sales?

    the negative i saw in the article is rosg only has a sales force of 4!

    they're going to have to sell their butts off to get to 20k sales or imcrease their sales force

    also, what are the margins?
    let's say the reimbursement rate is 2k

    what does it cost to make the kit?

    1k, couple of hundred bucks?

    dndn for example sells provenge for 96k but it costs them over 80k to make because it's so labor entensive

    how do you get to 20k sales and of that 20k, how much is profit?

    one other thing; the secondary is priced on the 22nd; depending on how the secondary is structured, we might/should see sec filings showing who the new buyers are if they own >5% of the company

    i'm really curious who the buyers are

    also, i don't expect those shrs to hit the market, i don't think they're going to buy in for 3.50 and flip'em for a quick double

    they're in for bigger gains

    this is going to be real interesting to watch

    gene ran from .86 to over 9 on their test kit and then crashed when they screwed up their secondary and their float was 14k or so

    agree with you in that double digits is the near term target and then everyone has to decide what to do

    gl

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ROSG
3.71+0.06(+1.64%)Aug 29 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.